Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Initial chemotherapy in gliomatosis cerebri.
Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY; ANOCEF group. Sanson M, et al. Among authors: taillibert s. Neurology. 2004 Jul 27;63(2):270-5. doi: 10.1212/01.wnl.0000129985.39973.e4. Neurology. 2004. PMID: 15277619 Clinical Trial.
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.
Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, Crinière E, Marie Y, Mokhtari K, Carpentier AF, Laigle F, Simon JM, Cornu P, Broët P, Sanson M, Delattre JY. Hoang-Xuan K, et al. Among authors: taillibert s. J Clin Oncol. 2004 Aug 1;22(15):3133-8. doi: 10.1200/JCO.2004.10.169. J Clin Oncol. 2004. PMID: 15284265
[Gliomatosis cerebri].
Sanson M, Napolitano M, Cartalat-Carel S, Taillibert S. Sanson M, et al. Among authors: taillibert s. Rev Neurol (Paris). 2005 Feb;161(2):173-81. doi: 10.1016/s0035-3787(05)85020-9. Rev Neurol (Paris). 2005. PMID: 15798516 Review. French.
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.
Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K. Kaloshi G, et al. Among authors: taillibert s. Neurology. 2007 May 22;68(21):1831-6. doi: 10.1212/01.wnl.0000262034.26310.a2. Neurology. 2007. PMID: 17515545
Bevacizumab and irinotecan for recurrent oligodendroglial tumors.
Taillibert S, Vincent LA, Granger B, Marie Y, Carpentier C, Guillevin R, Bellanger A, Mokhtari K, Rousseau A, Psimaras D, Dehais C, Sierra del Rio M, Meng Y, Laigle-Donadey F, Hoang-Xuan K, Sanson M, Delattre JY. Taillibert S, et al. Neurology. 2009 May 5;72(18):1601-6. doi: 10.1212/WNL.0b013e3181a413be. Neurology. 2009. PMID: 19414728
Supratentorial low-grade gliomas in older patients.
Kaloshi G, Psimaras D, Mokhtari K, Dehais C, Houillier C, Marie Y, Laigle-Donadey F, Taillibert S, Guillevin R, Martin-Duverneuil N, Sanson M, Hoang-Xuan K, Delattre JY. Kaloshi G, et al. Among authors: taillibert s. Neurology. 2009 Dec 15;73(24):2093-8. doi: 10.1212/WNL.0b013e3181c6781e. Epub 2009 Nov 11. Neurology. 2009. PMID: 19907009
[Improving the prognosis of glioma].
Sanson M, Taillibert S. Sanson M, et al. Among authors: taillibert s. Presse Med. 2004 Oct 23;33(18):1267. doi: 10.1016/s0755-4982(04)98904-x. Presse Med. 2004. PMID: 15611707 French. No abstract available.
[Therapeutic strategies and prospects of gliomas].
Taillibert S, Pedretti M, Sanson M. Taillibert S, et al. Presse Med. 2004 Oct 23;33(18):1278-83. doi: 10.1016/s0755-4982(04)98907-5. Presse Med. 2004. PMID: 15611710 Review. French.
91 results